Matinas Biopharma Holdings, Inc. · AMEX:MTNB
111 Equity Group LLC reported a 3.61% stake in Matinas Biopharma Holdings, Inc. (Schedule 13D/A)
Event Feb 13, 2025 · Filed Feb 19, 2025
111 Equity Group LLC reported a 3.61% stake in Matinas Biopharma Holdings, Inc., 183,639 shares, with active intent on Feb 13, 2025. Filed Feb 19, 2025 (Schedule 13D/A).
- Stake
- 3.61%
- Shares
- 183,639
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Chaim Herzog | 3.61% | 183,639 |
| 111 Equity Group LLC | 3.61% | 183,639 |
Source
Related
- Matinas Biopharma Holdings, Inc.
- 111 Equity Group LLC
- Matinas Biopharma Holdings, Inc. shareholders
- Schedule 13D · 111 Equity Group LLC · Jan 6, 2025
- Form 4 · Stern Adam K · Aug 13, 2026
- Schedule 13D/A · Stern Adam K · Aug 13, 2026
- Schedule 13G · Hezbay Holdings LLC · Jul 14, 2026
- Schedule 13G/A · Highbridge Capital Management LLC · Nov 14, 2025
- Schedule 13D/A · Hezbay Holdings LLC · Sep 25, 2025